Skip to main content
Oncoinvent ASA (OSL:ONCIN)
Norway flag Norway · Delayed Price · Currency is NOK
49.40
0.00 (0.00%)
Apr 28, 2026, 4:25 PM CET

Oncoinvent ASA Revenue

In the year 2025, Oncoinvent ASA had annual revenue of 28.07M NOK with 246.40% growth. Oncoinvent ASA had revenue of 16.11M in the half year ending December 31, 2025, with 192.20% growth.

Revenue
28.07M
Revenue Growth
+246.40%
P/S Ratio
7.88
Revenue / Employee
779.69K
Employees
36
Market Cap
221.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202528.07M19.97M246.40%
Dec 31, 20248.10M2.31M39.95%
Dec 31, 20235.79M-493.00K-7.85%
Dec 31, 20226.28M-4.80M-43.31%
Dec 31, 202111.08M705.85K6.80%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SoftOx Solutions AS 15.58M
Arctic Bioscience AS 45.90M
Aqua Bio Technology ASA 101.51M
EXACT Therapeutics AS 59.00K
Zelluna ASA 53.00K
Lytix Biopharma ASA 377.00K
ArcticZymes Technologies ASA 118.21M
Nykode Therapeutics AS 4.57M
Revenue Rankings

Oncoinvent ASA News

More News